Core Viewpoint - The company Sierte (002538) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact its financial statements and operations in the future [1][2]. Company Overview - Sierte is a modern high-tech listed company based in the Ningguo Economic and Technological Development Zone, specializing in the research, production, and sales of various fertilizers, including phosphate fertilizers and ecological fertilizers [2]. - The company has developed a strong industrial structure over more than 30 years, focusing on agricultural support and new emerging industries, ranking among the top in China's fertilizer and phosphate fertilizer sectors [2]. Financial Performance - For the first half of 2025, Sierte reported revenue of 2.183 billion yuan, a year-on-year increase of 7.15%, while net profit was 95.18 million yuan, reflecting a significant decline of 43.6% compared to the previous year [2]. - The increase in costs was attributed to rising international sulfur prices and significant increases in domestic sulfur, sulfuric acid, and potassium fertilizer procurement prices, leading to a decrease in gross profit margin [2]. Market Position - As of September 1, Sierte's stock price was 5.45 yuan per share, with a total market capitalization of 4.652 billion yuan [3].

雷达财经雷助吧出品 文|简白 编|深海 东财Choice数据显示，9月1日，际华集团成交额3.76亿元，主力净流出金额3313.35万元。 值得关注的是，8月8日，际华集团收到中国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告知书》（证监立案字03720252003号），因公司 涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司立案。 对此，四川鼎众律师事务所余君律师向雷达财经表示，上市公司信披不及时、不准确给投资者造成损失的，受损投资者可依法索赔。凡是在公司上市后至 2025年8月8日收盘之间买入，并在2025年8月8日收盘时继续持有际华集团股票的受损投资者可以参与索赔，可通过公号"雷助吧"（雷助码：66）报名，免费 参与索赔。获赔前无任何费用。 2024年6月14日，际华集团在北京市大兴区广茂大街44号院2号楼5层第一会议室召开了2023年年度股东大会。会议召集人是公司董事会，会议主持人是夏前 军董事长。公司在任董事7人，出席7人；公司在任监事3人，出席3人；公司董事会秘书出席了会议；公司部分高级管理人员列席了会议。 出席会议的股东和 ...

公司及董事会已先后在《2024年年度报告》《2025年半年度报告》的"第一节重要提示、目录和释义"中 进行"特别提示"，提示"随着有权机关对所涉事项检查、调查或侦查的进一步深入，涉案数额可能进一 步扩大，所涉事项对公司以前年度审前财务报表的影响也将进一步扩大，届时公司将根据有权机关的最 终检查、调查或侦查结论，再次依法依规调整、更正相关财务数据"。截至公告披露日，公司不存在其 他应披露未披露的重大事项，目前公司生产经营活动正常，该事项不会对公司生产经营产生重大影响。 司尔特（002538）(002538.SZ)发布公告，公司于2025年9月1日收到中国证券监督管理委员会(简称"中国 证监会")对公司送达的《立案告知书》(编号：证监立案字0232025004)，公司因涉嫌信息披露违法违 规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公 司进行立案。 ...

Core Viewpoint - The company, Sierte (002538.SZ), has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into suspected violations of information disclosure laws, leading to a formal case being opened against the company [1] Summary by Relevant Sections - **Investigation Details** - The CSRC has issued a "Notice of Case Filing" (No. 0232025004) against the company due to alleged violations of the Securities Law of the People's Republic of China and the Administrative Penalty Law [1] - **Company's Response** - The company and its board have highlighted in their 2024 Annual Report and 2025 Semi-Annual Report the potential for the investigation to expand, indicating that the amounts involved may increase and that the impact on previous financial statements could also grow [1] - **Current Operations** - As of the announcement date, the company reports that there are no other undisclosed significant matters and that its production and operational activities are normal, asserting that the investigation will not have a major impact on its operations [1]

Group 1 - Recent legal victories for investors against five listed companies due to information disclosure violations highlight the importance of fair capital market practices [1] - Companies involved include Hongbo Co., Ningbo Fangzheng, Zhuojin Co., *ST Jintai, and Yangzi New Materials, all facing lawsuits for false statements [1][10] - The court rulings provide a precedent for future investor claims, emphasizing the need for accurate and timely information disclosure [1][10] Group 2 - Hongbo Co. experienced a drastic change in profit forecast, revising from a profit of 37.4 million to a loss of 50 million, leading to significant stock price drops and investor losses [2][3] - Ningbo Fangzheng faced penalties for misusing funds, with 64.35 million yuan being transferred for non-operational purposes, constituting a significant violation of disclosure regulations [4][5] - Zhuojin Co. was penalized for misreporting costs, resulting in inflated profits and misleading financial statements, with some investors already compensated [6] - *ST Jintai was found to have engaged in fictitious gold trading, leading to substantial misstatements in financial reports, with a looming statute of limitations for claims [7][8] - Yangzi New Materials failed to disclose significant related party transactions, resulting in a court ruling that mandates compensation for affected investors [10][11] Group 3 - The collective lawsuits against these companies underscore the ongoing challenges in ensuring high-quality information disclosure in the capital market [12] - Investors are encouraged to take action to protect their rights, with specific conditions outlined for filing claims against the respective companies [5][11][12]

Core Viewpoint - Longli Biological, which engaged in financial fraud and was delisted after nine years, has recently faced a first-instance judgment in a securities false statement liability dispute, with the court ordering compensation for 1,618 investors [1][9]. Group 1: Legal Proceedings - The first-instance judgment revealed that 1,618 plaintiffs collectively hold investment loss claims amounting to 274 million yuan and legal fees of 809,000 yuan against Longli Biological [6]. - The defendant Cheng Shaobo is jointly liable for the debts owed by Longli Biological, while other defendants share joint liability within a certain percentage range, with Guolian Minsheng Securities bearing 5% of the joint liability [6][4]. Group 2: Company Background and Fraud Details - Longli Biological, established in June 2001, produces functional sugars and starches from corn and has been involved in biomass comprehensive utilization [7]. - The company was listed on the Shenzhen Stock Exchange in 2011, with Huaying Securities as its sponsor [7]. - Longli Biological faced delisting due to negative net assets for two consecutive years (2017 and 2018) and received audit reports that could not express an opinion, leading to its stock suspension in May 2019 and formal delisting in July 2020 [7][8]. Group 3: Regulatory Actions - In January 2018, the China Securities Regulatory Commission (CSRC) initiated an investigation into Longli Biological for suspected information disclosure violations [8]. - The CSRC identified Longli Biological as a typical case of financial fraud, revealing that from 2015 to mid-2017, the company inflated assets by nearly 500 million yuan, reduced liabilities by over 1.7 billion yuan, and inflated profits by approximately 140 million yuan [8]. - In January 2021, the CSRC issued administrative penalties against Longli Biological, including a fine of 600,000 yuan and a 1.5 million yuan fine against its actual controller Cheng Shaobo [8].

Group 1 - The core issue is that Jihua Group is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which could lead to potential compensation claims from affected investors [2] - On August 28, Jihua Group reported a transaction volume of 564 million yuan, with a net outflow of 55.4581 million yuan from major investors [2] - Investors who purchased Jihua Group's stock between its listing and the close on August 8, 2025, may be eligible for compensation if they suffered losses due to the company's delayed or inaccurate disclosures [2] Group 2 - As of May 30, 2025, Jihua Group reported a total of 109,300 ordinary shareholders in its latest periodic report [4] - The company has participated in 1,402 bidding projects and holds 433 trademark registrations, indicating its active engagement in the market [5] - Jihua Group has a history of producing military uniforms for significant national events, and it is expected to continue this role for the 80th anniversary of the Anti-Japanese War victory, although specific order details and revenue contributions are yet to be quantified [4]

Core Viewpoint - Langjin Technology (300594.SZ) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, but the company asserts that its operations remain stable and unaffected during the investigation [1]. Financial Performance - Langjin Technology has reported consecutive losses for three years, with revenues of 771 million yuan in 2022, 902 million yuan in 2023, and projected 881 million yuan in 2024, reflecting a decrease of 2.35% year-on-year [2][3]. - The net profit attributable to shareholders has been negative, with figures of -57.99 million yuan in 2022, -0.32 million yuan in 2023, and projected -76.41 million yuan in 2024, indicating a significant decline of 2,309.28% [3]. - The company’s cash flow from operating activities has also been negative, with -299 million yuan in 2022, -76.49 million yuan in 2023, and projected -101.73 million yuan in 2024, showing a 33% decrease [3]. Recent Developments - In the first half of 2025, Langjin Technology achieved revenue of 340 million yuan, a decline of 10.88% year-on-year, but reported a net profit of 1.48 million yuan, a recovery from a loss of 21.81 million yuan in the same period last year [4]. - The company’s basic earnings per share improved to 0.02 yuan from -0.24 yuan year-on-year, indicating a positive shift in financial performance [4].

Group 1 - The core issue is that Langjin Technology (300594) has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [2][5] - The company and its actual controller, Li Jingmao, received a notice of investigation on August 27, indicating that the CSRC has decided to file a case against them [2][5] - During the investigation, the company will actively cooperate with the CSRC and maintain communication with regulatory authorities, asserting that its production and operational activities remain normal and stable [5] Group 2 - Langjin Technology specializes in the research, production, sales, and after-sales maintenance of air conditioning for rail transit vehicles, new energy vehicles, intelligent thermal management products, air energy heat pump drying equipment, and digital energy intelligent environmental control products [5] - The latest semi-annual report shows that the company achieved operating revenue of 340 million yuan, a year-on-year decrease of 10.88%, while net profit was 1.4764 million yuan, a year-on-year increase of 106.77% [5] - The controlling shareholder of Langjin Technology is Langjin Group, which directly holds 19.035 million shares, accounting for 20.72% of the total shares [6]

朗进科技公告，公司于2025年8月27日收到中国证券监督管理委员会下发的《立案告知书》，因公司和 实际控制人之一李敬茂先生涉嫌信息披露违法违规，证监会决定对公司和李敬茂先生立案。在立案调查 期间，公司和李敬茂先生将积极配合调查，并严格按规定履行信息披露义务。目前公司生产经营活动正 常，本次立案不会对公司生产、经营和管理造成不利影响。 ...